I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Cost-effectiveness of roflumilast as an add-on to triple in..:
Kiff C
;
Ruiz S
;
Varol N
...
https://www.dovepress.com/cost-effectiveness-of-roflumilast-as-an-add-on-to-triple-inhaled-thera-peer-reviewed-article-COPD. , 2018
Link:
https://doaj.org/article/8c1ef2bd18ce40f3818cb79fb74e5..
RT Journal T1
Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy versus triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:8c1ef2bd18ce40f3818cb79fb74e5067&Exemplar=1&LAN=DE A1 Kiff C A1 Ruiz S A1 Varol N A1 Gibson D A1 Davies A A1 Purkayastha D PB Dove Medical Press YR 2018 K1 National Health Service K1 National Institute of Clinical Excellence K1 exacerbation rates K1 Diseases of the respiratory system K1 RC705-779 JF https://www.dovepress.com/cost-effectiveness-of-roflumilast-as-an-add-on-to-triple-inhaled-thera-peer-reviewed-article-COPD LK http://dx.doi.org/https://doaj.org/article/8c1ef2bd18ce40f3818cb79fb74e5067 DO https://doaj.org/article/8c1ef2bd18ce40f3818cb79fb74e5067 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)